Arcadia Biosciences, Inc. · XNAS · 131 sessions on record
$0.280.00 · −0.3%from $0.28 the session before · Sep 30, 2026 close · end of day
Open
$0.26
High
$0.29
Low
$0.22
Day's range
$0.0724% of the previous close
VWAP
$0.31close −9.4% from it
Volume, shares
21.1M13.35× the 20-session average
Traded, $
$6.5M
Trades
26.9K790 shares per trade
Previous close
$0.280.00 to the close
Market cap
$674.6Kat the close of Sep 30
Day range87% of the way up
$0.22$0.29
52-week range3% of the way up
$0.22 Sep 30$1.94 Jun 11
−86% from the high · +26% from the low
Options
No listed options on RKDA
Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it
consolidated · latest filed Aug 13, 2026 · SEC filings
Revenue $1.4M, −0.82% on a year earlier; profit −$6.3M in the Jun 2026 quarter, consolidated.
Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of RKDA on the consolidated basis with the market's move on the first session after each filing
Quarter
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
Market on the day
Jun 2026filed Aug 13
$1.4M
▼ −0.82%
−$6.3M
—
-2.09
▲ +9.6%S&P 500 −0.2% · +9.8 pp
Mar 2026filed May 14
$1.1M
▼ −8.3%
−$4.4M
▼ −270%
-2.11
▼ −10.7%S&P 500 −1.2% · −9.5 pp
Dec 2025filed Mar 26
$901.0K
▼ −26%
−$1.3M
—
-0.97
▼ −3.3%S&P 500 −1.7% · −1.6 pp
Sep 2025filed Nov 7
$1.3M
▼ −15%
$856.0K
—
0.62
—not reached
Jun 2025filed Aug 13
$1.5M
▲ +11%
−$4.5M
▼ −520%
-3.26
▲ +9.6%S&P 500 −0.2% · +9.8 pp
Mar 2025filed May 14
$1.2M
▲ +22%
$2.6M
—
1.90
▼ −10.7%S&P 500 −1.2% · −9.5 pp
Dec 2024filed Mar 25
$1.2M
▼ −19%
−$4.1M
—
-2.99
—not reached
Sep 2024filed Nov 7
$1.5M
▲ +18%
−$1.6M
—
-1.18
—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of RKDA on the consolidated basis, summed from the quarters filed
Year
Revenue $
Revenue YoY
Profit $
Profit YoY
EPS $
FY25to Dec 2025
$4.9M
▼ −3.7%
−$2.3M
—
-1.71
FY24to Dec 2024
$5.0M
▲ +13%
−$7.0M
—
-5.17
FY23to Dec 2023
$4.5M
▼ −40%
−$14.0M
—
-11.29
FY22to Dec 2022
$7.4M
▲ +9.4%
−$15.4M
—
-25.65
FY21to Dec 2021
$6.8M
▼ −16%
−$14.7M
—
-27.56
Fundamentals
consolidated · filings to Jun 2026 · close $0.28 on Sep 30
0.11 times book value, revenue −12% over twelve months, market cap $674.6K.
Valuation
Market cap
$674.6Kon Sep 30
Price to earnings
—
Trailing EPS
$-4.55diluted · consolidated · four quarters to Jun 2026
Price to book
0.11consolidated · balance sheet to Dec 2024
Book value a share
$2.58consolidated · balance sheet to Dec 2024
Debt to equity
—
Return on equity
-180%trailing profit over average equity · consolidated
Dividend yield
—
Price to sales
0.14market cap over revenue, four quarters to Jun 2026
Shares outstanding
2.41Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
$4.7Mfour quarters to Jun 2026
Revenue growth, 12 months
▼ −12%against the twelve months before
Revenue 3-year CAGR
▼ −4.2%trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
−$11.1Mfour quarters to Jun 2026
Profit growth, 12 months
—
Profit 3-year CAGR
—
PeersCrude Petroleum & Natural Gas · the ten largest by market cap · industry P/E 24, market caps over trailing profit of 3 stocks
Stocks in the industry Crude Petroleum & Natural Gas with market cap, price to earnings and price to book
Crude Petroleum & Natural Gas · SEC standard industrial classification
SEC CIK
1469443
Sessions on record
131
Price source
End of day · delayed
Computed
2 Oct, 03:17 am IST
OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.